TCL Archive NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure October 23, 1998
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive Push to Get Exceptions, Adjustments For Clinical Research In DRG Regulations Gaining Momentum July 22, 1983
TCL Archive HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds March 26, 1982
TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007